{{Rsnum
|rsid=2844482
|Gene=LTA
|Chromosome=6
|position=31571990
|Orientation=minus
|GMAF=0.1276
|Gene_s=HLA-DQA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 30.1 | 69.9
| HCB | 2.2 | 27.0 | 70.8
| JPT | 0.9 | 18.6 | 80.5
| YRI | 1.4 | 19.0 | 79.6
| ASW | 0.0 | 21.1 | 78.9
| CHB | 2.2 | 27.0 | 70.8
| CHD | 3.7 | 32.1 | 64.2
| GIH | 5.0 | 33.7 | 61.4
| LWK | 1.8 | 26.4 | 71.8
| MEX | 1.8 | 24.6 | 73.7
| MKK | 0.0 | 12.2 | 87.8
| TSI | 2.9 | 28.4 | 68.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=20217072
|Title=SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine
|OA=1
}}

{{PMID|17595314}} Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample.

{{PMID|18805939|OA=1
}} Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis.

{{PMID|20668555|OA=1
}} Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.

{{PMID Auto
|PMID=23051989
|Title=Investigation of lymphotoxin alpha genetic variants in migraine.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}